Heron Therapeutics (HRTX)
NASDAQ:HRTX
Heron Therapeutics (HRTX) Ownership Overview
21.29% Insiders
7.95% Mutual Funds
50.90% Other Institutional Investors
8.59% ETFs
11.27% Public Companies and
Individual Investors
The ownership structure of Heron Therapeutics (HRTX) stock is a mix of institutional, retail, and individual investors. Approximately 67.44% of the company’s stock is owned by Institutional Investors, 21.29% is owned by Insiders, and 11.27% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 12, 2025 | xxxxxxxxxxxxx | $2649819 | |
Aug 12, 2025 | xxxxxxxxxxxxx | $3580838 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 30,046,828 | Insider | 15.94% | 26,020,553 | |
| 8,877,027 | Insider | 4.71% | 7,687,505 | |
| 8,813,258 | Institution | 4.67% | 7,632,281 | |
| 7,089,717 | Institution | 3.76% | 6,139,695 | |
| 5,672,883 | Institution | 3.01% | 4,912,717 | |
| 4,251,951 | Institution | 2.26% | 3,682,190 | |
| 1,733,568 | Institution | 0.92% | 1,501,270 | |
| 1,462,014 | Institution | 0.78% | 1,266,104 | |
| 966,236 | Institution | 0.51% | 836,760 | |
| 865,459 | Institution | 0.46% | 749,487 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,089,717 | Institution | 3.76% | 6,139,695 | |
| 1,733,568 | Institution | 0.92% | 1,501,270 | |
| 1,462,014 | Institution | 0.78% | 1,266,104 | |
| 865,459 | Institution | 0.46% | 749,487 | |
| 606,366 | Institution | 0.32% | 525,113 | |
| 453,805 | Institution | 0.24% | 392,995 | |
| 425,864 | Institution | 0.23% | 368,798 | |
| 421,984 | Institution | 0.22% | 365,438 | |
| 419,057 | Institution | 0.22% | 362,903 | |
| 396,923 | Institution | 0.21% | 343,735 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,474,947 | Institution | 2.90% | 7,226,930 | |
| 3,860,018 | Institution | 2.05% | 3,343,934 | |
| 2,028,470 | Institution | 1.08% | 2,677,580 | |
| 1,148,414 | Institution | 0.61% | 994,871 | |
| 884,269 | Institution | 0.47% | 793,366 | |
| 759,201 | Institution | 0.40% | 903,449 | |
| 421,248 | Institution | 0.22% | 556,047 | |
| 408,027 | Institution | 0.22% | 353,474 | |
| 233,002 | Institution | 0.12% | 201,850 | |
| 219,878 | Institution | 0.12% | 190,480 |
FAQ
Who Owns Heron Therapeutics (HRTX)?
According to the latest TipRanks data, approximately 50.90% of the company's stock is held by institutional investors, 21.29% is held by insiders, and 11.27% is held by retail investors.
What percentage of Heron Therapeutics (HRTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 50.90% of Heron Therapeutics (HRTX) stock is held by institutional investors.
What percentage of Heron Therapeutics (HRTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 11.27% of Heron Therapeutics (HRTX) stock is held by retail investors.
Who owns the most shares of Heron Therapeutics (HRTX)?
Rubric Capital Management LP owns the most shares of Heron Therapeutics (HRTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.